- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01786148
Music for Health Project (MFH)
An Audio Music Self-Management Program to Improve ART Adherence in Rural GA
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The project has two primary aims and one exploratory aim. 1.0 Revise and adapt the Live Network (LN) program and manual for rural persons living with HIV/AIDS (PLWHA) and develop into a mobile application.
2.0 Conduct a randomized controlled trial to test the efficacy of the program. When compared with an educational music control condition at 3, 6, and 9 months post-baseline, those randomized to the LN will have: H1: Significantly higher mean antiretroviral therapy (ART) adherence rates (measured by pill counts, self report).
H2: Significantly higher mean levels of ART drug levels in hair sample analyses.
H3: Significantly better clinical indicators: higher mean CD4 lymphocyte counts and percents, a larger proportion achieving virologic suppression (proportion with HIV RNA PCR <50 copies/ml), and smaller proportion with evidence of drug resistance, all as measured by medical record review.
3.0 Explore: a) the effects of LN on symptoms and symptom management; b) the roles of self-efficacy, outcome expectancies, and personal goal setting as mediators, and depression and health literacy as moderators of adherence.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Georgia
-
Atlanta, Georgia, États-Unis, 30322
- Emory University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- HIV+ individuals initiating ART for the first time (except women who may have had ART during pregnancy); or HIV+ individuals changing ART regimen within the past 3 months due to side effects or virologic resistance; or HIV+ individuals with a detectable viral load ≥ 40copies/ml; or HIV+ individuals on ART medication
- English speaking
- Willing to complete 4 assessments
- Willing to complete monthly, unannounced pill counts
- Willing to allow collection of hair samples
- Willing to be randomly assigned to either condition
- Willing to participate in study activities that include using smart phone and mobile app
Exclusion Criteria:
- Have a history of bilateral hearing loss (health care provider diagnosed or self-identified)
- Homeless
- Have a cognitive impairment (inability to comprehend the informed consent)
- Display psychotic symptoms, as determined by the Brief Symptom Inventory (BSI)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur actif: Educational music mobile app
A prerecorded program of songs on various topics in a mobile phone application (app).
It is designed to provide education about non-health related topics and will be equivalent in length to the intervention app.
|
|
Expérimental: Live Network mobile phone App
The LN is a prerecorded mobile phone application (app).
It employs a radio talk show format in which a Disc Jockey entertains HIV medication-, adherence-, and self-management-related questions and comments from callers and poses them to expert care providers, whose responses to these questions are augmented by songs that shed additional light on these issues.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change in Antiretroviral Therapy (ART) Adherence Rates
Délai: Baseline, 3 months post-baseline, 6 months post-baseline and 9 months post-baseline
|
Adherence rate was measured with the Antiretroviral General Adherence Scale (AGAS) which measures the general ease and ability to take one's medication as prescribed in the past 30 days.
It includes 5 items scored 1 to 6, with the possible scores for this instrument ranging from 5 to 30, and higher scores reflect better adherence.
|
Baseline, 3 months post-baseline, 6 months post-baseline and 9 months post-baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change in Antiretroviral (ART) Drug Levels in Hair Sample Analyses.
Délai: 3, 6, and 9 months post-baseline
|
No data available due to inability of the lab to accurately extract drug from hair.
|
3, 6, and 9 months post-baseline
|
Clinical Indicator: Change in Mean CD4 Percentage
Délai: Baseline, 3 months post-intervention, 6 months post-intervention, 9 months post-intervention, 9 to 12 months post-intervention
|
CD4 count is a test that measures the number of CD4 cells in your blood.
CD4 cells, also known as T cell lymphocytes, are white blood cells that fight infection and play an important role in your immune system.
A CD4 count is used to check the health of the immune system in people infected with HIV (human immunodeficiency virus).
The count measures the number of CD4 cells in a small sample of blood.
The percent of CD4 cells measure the percentage of all lymphocytes that are CD4 cells.
The study assesses the percentage of CD4 lymphocytes over time.
|
Baseline, 3 months post-intervention, 6 months post-intervention, 9 months post-intervention, 9 to 12 months post-intervention
|
Clinical Indicator: Number of Participants With Non-detectable Viral Load
Délai: Baseline, 3 months post-intervention, 6 months post-intervention, 9 months post-intervention, 9 to 12 months post-intervention
|
Change in number of participants with viral load presented as number of copies if <50 copies versus ≥ 50 copies.
Subjects were coded as having non-detectable viral loads if the "load" was < 50 copies.
The analyses performed reflects the number of subjects with non-detectable load (<50) at Baseline, 3 months post-intervention, 6 months post-intervention, 9 months post-intervention, 9 to 12 months post-intervention.
|
Baseline, 3 months post-intervention, 6 months post-intervention, 9 months post-intervention, 9 to 12 months post-intervention
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Marcia M Holstad, PhD, Emory University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Infections par virus à ARN
- Maladies virales
- Infections
- Infections transmissibles par le sang
- Maladies transmissibles
- Maladies sexuellement transmissibles, virales
- Maladies sexuellement transmissibles
- Infections à lentivirus
- Infections à rétroviridae
- Syndromes d'immunodéficience
- Maladies du système immunitaire
- Maladies à virus lents
- Infections à VIH
- Syndrome immunodéficitaire acquis
Autres numéros d'identification d'étude
- IRB00055077
- 1R01NR012923 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Virus de l'immunodéficience humaine
-
Jinling Hospital, ChinaInconnueMaladie de Crohn | Méthylation | Illumina Human Methylation 850k BeadChipChine
Essais cliniques sur mobile phone application
-
Sense A/SRetiréHypertension | En bonne santé | Hypotension
-
Ankara City Hospital BilkentComplétéDiabète de type 1Turquie
-
Aydin Adnan Menderes UniversityComplété
-
Centre Integre Universitaire de Sante et Services...RecrutementHypertension | Maladie rénale chronique | Pression artérielleCanada
-
University Medicine GreifswaldComplété